Publicaciones

2024

Biodistribution and pharmacokinetics of [⁸⁹Zr]-anti-VEGF mAbs using PET in glioblastoma rat models.

Lara García-Varela, Jessica Codesido, Alberto Perez-Pedrosa, María Muñoz-González, Emma Ramos-Docampo, David Rey-Bretal, Xurxo García-Otero, Noemí Gómez-Lado, Angela Turrero, Daniel Beiroa, Ana Isabel Rodríguez-Perez, Anxo Vidal, Anxo Fernández-Ferreiro, Virginia Pubul, Pablo Aguiar.

International Journal of Pharmaceutics, Volume 652, 2024,123795, ISSN 0378-5173.

Molecular Imaging Biomarkers and Pharmacokinetic Modelling

Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity.

Costoya-Sánchez A, Moscoso A, Silva-Rodríguez J, Pontecorvo MJ, Devous MD Sr, Aguiar P, Schöll M, Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative and the Harvard Aging Brain Study.

JAMA Neurol. 2023 Oct 1;80(10):1051-1061.

Molecular Imaging Biomarkers and Pharmacokinetic Modelling

2023

8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies.

Matos M J, Novo P, Mayán L, Torres I, Uriarte E, Yáñez M, Fontenla JÁ, Ortuso F, Alcaro S, Procopio F, Rodríguez-Franco MI, Val C, Loza MI, Brea J, Borges F, Viña D.

Volume 248, 15 February 2023, 115091

Pharmacology of Chronic Diseases

AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability

Maria A. Pedrosa, Carmen M. Labandeira, RitaValenzuela, Aloia Quijano, Mariña Sanchez-Andrade, Juan A. Suarez-Quintanilla, Jose L. Lanciego, Jose L. Labandeira-Garcia, Ana I. Rodriguez-Perez

Brain, Behavior, and Immunity, Volume 108, February 2023, Pages 255-268

Cell and Molecular Neurobiology of Parkinson's Disease

Cancer cells escape the immune system by increasing stemness through epigenetic reprogramming

Costoya, J.A., Arce, V.M.

Cell Mol Immunol 20, 6–7 (2023).

Molecular Oncology Laboratory